Gastrointestinal Stromal Tumors Therapeutics Market Industry Analysis, Growth, Trends and Forecast – 2028

Gastrointestinal stromal tumors therapeutics market share is expected to increase by USD 1.08 billion from 2021 to 2028, and the market’s growth momentum will accelerate at a CAGR of 5%.

Gastrointestinal stromal tumors are the most common mesenchymal tumors in the world. The benign form of gastrointestinal stromal tumors can occur in any part of the gastrointestinal tract. In many cases, it spreads to other parts of the body, creating a more serious condition. Because of this, current research is focused on gene therapy that can stop tumors and make them recur.

Key players

• Ascentage Pharma Group International
• AB Science SA
• Bayer AG
• Blueprint Medicines Corp
• Bristol Myers Squibb Co.
• Deciphera Pharmaceuticals Inc
• Immunicum AB
• NATCO Pharma Ltd.
• Novartis AG
• Pfizer Inc.
• Sumitomo Pharma Oncology Inc.
• Sun Pharmaceutical Industries Ltd
• Xencor Inc.
• Arog Pharmaceuticals Inc

 

Market Segmentation

The global gastrointestinal stromal tumors therapeutics market is segmented on the basis of administration and distribution channel. Based on rote of administration, the market is bifurcated into oral and parenteral. Based on distribution channel the market is classified as hospital pharmacies, retail pharmacies and online pharmacies.

 

Scope of the report

The research study analyses the Gastrointestinal Stromal Tumors Therapeutics Market from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North America market size and/or volume
• Latin America market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Gastrointestinal Stromal Tumors Therapeutics Market Report

• What was the Gastrointestinal Stromal Tumors Therapeutics Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the Gastrointestinal Stromal Tumors Therapeutics Market CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Gastrointestinal Stromal Tumors Therapeutics Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.